S. Ous

1.1k total citations
37 papers, 816 citations indexed

About

S. Ous is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, S. Ous has authored 37 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in S. Ous's work include Testicular diseases and treatments (22 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Sarcoma Diagnosis and Treatment (9 papers). S. Ous is often cited by papers focused on Testicular diseases and treatments (22 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Sarcoma Diagnosis and Treatment (9 papers). S. Ous collaborates with scholars based in Norway, Taiwan and Denmark. S. Ous's co-authors include Sophie D. Fosså, Anna E. Stenwig, H. H. Lien, Mitchell Loeb, Thomas Åbyholm, S.D. Fosså, Nina Aass, Håkon Wæhre, Nils Norman and H. Qvist and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Radiology.

In The Last Decade

S. Ous

37 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Ous Norway 18 676 243 191 168 134 37 816
R. E. Drasga United States 7 388 0.6× 198 0.8× 194 1.0× 74 0.4× 167 1.2× 9 629
John W. Cullen United States 18 773 1.1× 286 1.2× 326 1.7× 118 0.7× 166 1.2× 29 1.1k
C. Clemm Germany 16 564 0.8× 146 0.6× 188 1.0× 167 1.0× 123 0.9× 35 654
Sigurd Ous Norway 15 615 0.9× 110 0.5× 136 0.7× 163 1.0× 91 0.7× 25 659
K.‐P. Dieckmann Germany 17 766 1.1× 348 1.4× 210 1.1× 236 1.4× 414 3.1× 56 939
D Ondruš Slovakia 13 530 0.8× 158 0.7× 257 1.3× 148 0.9× 199 1.5× 98 791
Francisco H. Dexeus United States 14 562 0.8× 72 0.3× 287 1.5× 120 0.7× 168 1.3× 21 866
Tullio Torelli Italy 19 834 1.2× 124 0.5× 222 1.2× 357 2.1× 147 1.1× 77 932
Fulvio Zanoni Italy 13 430 0.6× 132 0.5× 145 0.8× 143 0.9× 140 1.0× 23 468
R E Alison Canada 13 454 0.7× 107 0.4× 221 1.2× 159 0.9× 147 1.1× 17 704

Countries citing papers authored by S. Ous

Since Specialization
Citations

This map shows the geographic impact of S. Ous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ous more than expected).

Fields of papers citing papers by S. Ous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ous. The network helps show where S. Ous may publish in the future.

Co-authorship network of co-authors of S. Ous

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ous. A scholar is included among the top collaborators of S. Ous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ous. S. Ous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobsen, Kari Dolven, S. Ous, Håkon Wæhre, et al.. (1999). Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. British Journal of Cancer. 80(1-2). 249–255. 60 indexed citations
2.
Dueland, Svein, AE Stenwig, Arne Heilo, et al.. (1998). Treatment and outcome of patients with extragonadal germ cell tumours - the Norwegian Radium Hospital's experience 1979-94. British Journal of Cancer. 77(2). 329–335. 18 indexed citations
3.
4.
Fosså, S.D., et al.. (1993). Semen Quality after Treatment forTesticular Cancer. European Urology. 23(1). 172–176. 24 indexed citations
5.
Josefsen, Dag, S. Ous, J Høie, AE Stenwig, & S.D. Fosså. (1993). Salvage treatment in male patients with germ cell tumours. British Journal of Cancer. 67(3). 568–572. 26 indexed citations
6.
Jacobsen, Anne-Birgitte, et al.. (1992). DNA Flow Cytometry and Neo-Adjuvant Chemotherapy/ Radiotherapy in Operable Muscle- Invasive Bladder Carcinoma. European Urology. 22(4). 316–322. 6 indexed citations
7.
Fosså, Sophie D., H. Qvist, Anna E. Stenwig, et al.. (1992). Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?. Journal of Clinical Oncology. 10(4). 569–573. 90 indexed citations
8.
Fosså, S. D., Nina Aass, S. Ous, & Håkon Wæhre. (1991). Long—Term Morbidity and Quality of Life in Testicular Cancer Patients. Scandinavian Journal of Urology and Nephrology. 25(sup138). 241–246. 18 indexed citations
9.
Fosså, Sophie D., S. Ous, & A. Berner. (1991). Clinical Significance of the “Palpable Mass” in Patients with Muscle‐infiltrating Bladder Cancer Undergoing Cystectomy after Pre‐operative Radiotherapy. British Journal of Urology. 67(1). 54–60. 24 indexed citations
10.
Fosså, Sophie D., et al.. (1990). Management of Patients with Poor-Prognosis Nonseminomatous Germ Cell Cancer. Oncology. 47(3). 234–240. 7 indexed citations
11.
Aass, Nina, Sophie D. Fosså, S. Ous, et al.. (1990). Is Routine Primary Retroperitoneal Lymph Node Dissection Still Justified in Patients with Low Stage Non‐seminomatous Testicular Cancer?. British Journal of Urology. 65(4). 385–390. 20 indexed citations
12.
Jacobsen, Anne-Birgitte, S. Ous, Jan Egil Melvik, et al.. (1989). Bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values. International Journal of Radiation Oncology*Biology*Physics. 17(5). 923–929. 16 indexed citations
13.
Sæter, Gunnar, et al.. (1988). Changes in Ploidy Distributions in Human Liver Carcinogenesis. JNCI Journal of the National Cancer Institute. 80(18). 1480–1484. 47 indexed citations
14.
Fosså, Sophie D., et al.. (1988). Evaluation of response by CT in patients with advanced bladder cancer treated with cisplatinum/methotrexate.. PubMed. 260. 499–510. 1 indexed citations
15.
Fosså, S.D., et al.. (1988). Late recurrence of testicular cancer.. Journal of Clinical Oncology. 6(8). 1248–1253. 66 indexed citations
16.
Fosså, Sophie D., et al.. (1987). Contrast-Enhanced Computed Tomography to Show Perivesical Extension in Bladder Carcinoma. Acta Radiologica. 28(3). 307–311. 7 indexed citations
17.
Lien, H. H., Anna E. Stenwig, S. Ous, & Sophie D. Fosså. (1986). Influence of Different Criteria for Abnormal Lymph Node Size on Reliability of Computed Tomography in Patients with Non-Seminomatous Testicular Tumor. Acta Radiologica Diagnosis. 27(2). 199–203. 30 indexed citations
18.
Fosså, Sophie D., et al.. (1985). Short-Term and Long-Term Effect of Prophylactic Treatment ofSuperficial Bladder Cancer with Intravesical Adriamycin. European Urology. 11(6). 382–385. 4 indexed citations
19.
Fosså, Sophie D., S. Ous, Thomas Åbyholm, Nils Norman, & Mitchell Loeb. (1985). Post‐treatment Fertility in Patients with Testicular Cancer.: II. Influence of Cis‐platin‐based Combination Chemotherapy and of Retroperitoneal Surgery on Hormone and Sperm Cell Production. British Journal of Urology. 57(2). 210–214. 68 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026